HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Boris Sepesi Selected Research
Boris Sepesi Research Topics
Disease
70
Neoplasms (Cancer)
04/2024 - 04/2010
51
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 01/2016
33
Lung Neoplasms (Lung Cancer)
05/2024 - 01/2017
22
Adenocarcinoma
03/2024 - 12/2009
8
Malignant Mesothelioma
01/2023 - 01/2018
7
Esophageal Neoplasms (Esophageal Cancer)
04/2024 - 12/2010
7
Neoplasm Metastasis (Metastasis)
10/2022 - 12/2016
7
Adenocarcinoma of Lung
10/2022 - 10/2017
5
Mesothelioma
01/2023 - 01/2019
5
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2022 - 01/2017
4
Colorectal Neoplasms (Colorectal Cancer)
07/2023 - 09/2019
4
Carcinoma (Carcinomatosis)
01/2023 - 09/2013
3
Disease Progression
05/2024 - 12/2016
3
Hemorrhage
01/2021 - 12/2017
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 04/2017
2
Chronic Obstructive Pulmonary Disease (COPD)
06/2023 - 09/2020
2
Postoperative Pain
12/2021 - 01/2020
2
Inflammation (Inflammations)
07/2021 - 01/2019
2
Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021 - 02/2018
2
Pneumonia (Pneumonitis)
01/2021 - 01/2018
2
Coronary Artery Disease (Coronary Atherosclerosis)
09/2020 - 12/2017
2
Sepsis (Septicemia)
02/2018 - 07/2010
2
Infections
02/2018 - 06/2017
1
Chylothorax
02/2024
1
Lymphatic Metastasis
11/2023
1
Esophageal Squamous Cell Carcinoma
12/2022
1
Squamous Cell Neoplasms (Squamous Cell Cancer)
12/2022
1
Pain (Aches)
12/2021
1
Urinary Retention
09/2021
1
COVID-19
03/2021
1
Adenocarcinoma in Situ
01/2021
1
Pathologic Complete Response
01/2021
1
Granuloma
01/2021
1
Hyperplasia
01/2021
1
Metaplasia
01/2021
1
Acute Kidney Injury (Acute Renal Failure)
01/2021
Drug/Important Bio-Agent (IBA)
14
Biomarkers (Surrogate Marker)
IBA
02/2023 - 10/2017
12
Immune Checkpoint Inhibitors
IBA
10/2023 - 01/2018
5
Nivolumab
IBA
05/2024 - 01/2021
5
Opioid Analgesics (Opioids)
IBA
11/2023 - 10/2019
5
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2021 - 10/2017
4
Ipilimumab
IBA
10/2023 - 01/2021
4
RNA (Ribonucleic Acid)
IBA
10/2021 - 06/2017
4
Oxygen (Dioxygen)
IBA
09/2021 - 01/2013
4
B7-H1 Antigen
IBA
07/2021 - 01/2018
4
Paraffin
IBA
01/2021 - 06/2017
3
Cisplatin (Platino)
FDA Link
Generic
01/2022 - 02/2018
3
Cytokines
IBA
01/2020 - 01/2018
3
Ligands
IBA
01/2018 - 10/2017
3
Formaldehyde (Formol)
FDA Link
01/2018 - 06/2017
2
Eosine Yellowish-(YS) (Eosin)
IBA
10/2023 - 11/2021
2
Hematoxylin (Haematoxylon)
IBA
10/2023 - 11/2021
2
Antigens
IBA
01/2023 - 01/2017
2
Adenosine (Adenocard)
FDA Link
Generic
07/2021 - 01/2021
2
Docetaxel (Taxotere)
FDA Link
01/2020 - 02/2018
1
atezolizumab
IBA
03/2024
1
Octreotide (Sandostatin)
FDA Link
Generic
02/2024
1
Melanocyte-Stimulating Hormones (MSH)
IBA
01/2024
1
Synaptophysin
IBA
01/2023
1
Chromogranin A
IBA
01/2023
1
Deoxyglucose (2 Deoxy D glucose)
IBA
10/2022
1
N 30
IBA
07/2022
1
Bevacizumab (Avastin)
FDA Link
07/2022
1
Tyrosine Kinase Inhibitors
IBA
07/2022
1
Interleukins
IBA
01/2022
1
urelumab
IBA
01/2022
1
osimertinib
IBA
01/2022
1
Interleukin-2 (IL2)
IBA
01/2022
1
Antibodies
IBA
01/2022
1
Enzymes
IBA
07/2021
1
Phenobarbital (Luminal)
FDA Link
07/2021
1
Peptide Hydrolases (Proteases)
FDA Link
03/2021
1
hydrogen sulfite (bisulfite)
IBA
01/2021
1
Ketorolac
IBA
01/2021
1
Dasatinib (BMS 354825)
FDA Link
10/2020
Therapy/Procedure
50
Therapeutics
11/2023 - 04/2010
27
Neoadjuvant Therapy
12/2023 - 10/2010
22
Immunotherapy
12/2023 - 01/2017
18
Drug Therapy (Chemotherapy)
05/2024 - 12/2016
13
Esophagectomy
04/2024 - 12/2009
9
Radiotherapy
02/2022 - 05/2017
5
Aftercare (After-Treatment)
10/2022 - 10/2017
5
Pneumonectomy (Lung Volume Reduction)
01/2022 - 01/2017
4
Adjuvant Chemotherapy
01/2022 - 10/2017
3
Metastasectomy
07/2023 - 09/2019
3
Thoracotomy
12/2021 - 01/2018
3
Induction Chemotherapy
01/2019 - 01/2019
2
Length of Stay
04/2024 - 01/2018
2
Cardiopulmonary Resuscitation (CPR)
10/2023 - 11/2022
2
Patient Readmission
06/2023 - 01/2020
2
Enhanced Recovery After Surgery
12/2021 - 01/2019
2
Cranial Irradiation
03/2021 - 01/2017
2
Operative Surgical Procedures
01/2019 - 01/2017
2
Stents
12/2017 - 07/2010
2
Chemoradiotherapy
01/2016 - 09/2013
1
Combination Drug Therapy (Combination Chemotherapy)
01/2023
1
Molecular Targeted Therapy
02/2022
1
Analgesia
12/2021
1
Blood Transfusion (Blood Transfusions)
09/2021
1
Chest Tubes (Chest Tube)
09/2021